CIK 0001655759 · Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472566120
- Phone
- 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-12 | Peck Ronald Chief Medical Officer | Sale | −1,258 | $68.99 | $87K | 8,154 |
| 2022-08-12 | Peck Ronald Chief Medical Officer | Option exercise · Restricted Stock Units | −4,010 | 4,010 | ||
| 2022-06-16 | DIXON WENDY L Director | Grant or award · Stock Option (right to buy) | +10,192 | 10,192 | ||
| 2022-06-16 | SHANNON TIMOTHY M Director | Grant or award · Stock Option (right to buy) | +10,192 | 10,192 |
Page 10 of 10 · 184 trades